Mirum Pharmaceuticals (MIRM) Stock Highlights

41.51 | +0.92%

2024-12-21 03:34:41

Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of therapies for debilitating liver diseases. It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.

Statistics

Range Today

40.58 42.85

Volume Today 1.19M

Range 1 Year

23.14 48.89

Volume 1 Year 137.47M

Range 3 Year

14.63 48.89

Volume 3 Year 335.19M

Range 10 Year

6.513 48.89

Volume 10 Year 419.96M

Highlights

Market Capitalization 2B (mid)

Floating Shares 36.01M

Current Price 41.51

Price To Earnings -17.43

Price To Revenue 7.72

Price To Book 8.72

Earnings Per Share -2.36

Payout Ratio 0%

Performance

Latest +0.92%

1 Month -1.42%

3 Months +5.2%

6 Months +38.37%

1 Year +31.28%

3 Years +178.4%

5 Years +75.74%

10 Years +219.31%

Benchmarks

Market Capitalization

105 / 368

Gross Profits

57 / 278

Total Revenue

77 / 300

Total Rank

202 / 368

Free Cashflow

270 / 352

Performance 5 years

67 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.